Found 206 matching trials
Pancreas Allotransplantation for Diabetic Nephropathy and Mild Chronic REnal fAilure Stage Study
PHASE3Current medical therapies are not able to prevent progression of establishe...
Location
University of Minnesota
A 12-week Pilot Nutrition Intervention for Children With New Diagnosis of Stage 3 Type 1 Diabetes (T1D)
NAThe purpose of this research study is to investigate the effects of a combi...
Status
Active Not Recruiting
Location
Penn State Health Children's
Intensive Insulin Therapy in Patients Undergoing Coronary Artery Bypass Surgery
PHASE3High blood glucose levels (hyperglycemia) in cardiac surgery patients with ...
Location
Emory University Hospital
Effects of Intensive Bolus Intravenous Insulin Delivery on Metabolic Integrity in Type 1 and Type 2 Diabetes
PHASE3The purpose of this study is to determine if restoring normal metabolic fun...
Location
Global Infusion and Aspiration Systems, LLC
Impact of Short-term Intensive De-escalation Therapy on Long-term Regimen Simplification
PHASE4Despite advances in diabetes management, many patients with type 2 diabetes...
Location
Department of endocrinology, FAH-SYSU
Closed-loop Glucose Control for Automated Management of Type 1 Diabetes
NAWe hypothesize that our integrated closed-loop glucose-control system can p...
Location
Massachusetts General Hospital
KULeuven Intensive Insulin Therapy Study in Medical Intensive Care Patients
PHASE2In a previous study, we showed that tight blood glucose control with insuli...
Location
Catholic University of Leuven, University Hospital Gasthuisberg
Humalog or Humulin for Intensive Insulin Therapy in Intensive Care Unit
PHASE4Insulin preparation -random assignment to regular insulin lin or lispro ins...
Location
University of ROme "La Sapienza" Rome Italy
Effect of Metabolic Control at Onset of Diabetes on Progression of Type 1 Diabetes
PHASE2The purpose of this study is to find out if very tight blood glucose contro...
Location
Stanford University
The Potential of Dapagliflozin Plus Exenatide in Obese Insulin-resistant Patients
PHASE3This is a 28-week, multi-center, randomized, double-blind, placebo-controll...
Location
Diabeteszentrum Oldenburg